[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:inactive-tyrosine-protein-kinase-transmembrane-receptor-ror1":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Inactive Tyrosine-Protein Kinase Transmembrane Receptor ROR1",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07612176","A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:18:23.582895Z","2026-05-29T15:36:40.230934Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05279300","A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas",[11],"2026-08-03T03:04:17.166945Z","2026-04-29T02:57:57.124452Z"]